Login
Toggle navigation
Videos
Categories
Trending
Flash is missing. Download it from
Adobe
.
Jim Cramer sits down with RingCentral's CEO to discuss the company's role in the cloud and subscription economy.
00:10:00
Watch Full Video
×
Please Login to watch Full video
Login
+ ADD TO Wishlist
×
Please login
Login
Share On Facebook
Share On Twitter
Vlad Shmunis is the Founder, Chairman, and CEO of RingCentral.
Recent Videos
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences
Suggestions
00:10:00
Interview with Sir Douglas Flint on Climate Adaptation and Financial Institutions|Sir Douglas Flint CBE,Chairman,Aberdeen Standard
00:10:00
Charting the Future: ESG, Active Management, and the Blockchain Revolution| Hanneke Smits, CEO , The Bank of New York Mellon Corporation.
00:10:00
BIXOLON Showcases its latest Product Innovations at EuroCIS 2022 | Hyoun Chall Roh, CEO, Bixolon Co Ltd9319K:KOE
00:10:00
2008 / Q4 (1/7) THE BANGCHAK PETROLEUM PCL | Chaiwat Kovavisarach, CEO, Bangchak Corporation PCLBCP:SET
00:10:00
A Conversation with Shuhai Abe on Japan's Economic Potential and Investment Strategies | Shuhei Abe , CEO , SPARX Group.
00:10:00
The Dealmaker: Insights from Guy Hands on Decades of Private Equity | Guy Hands, Chairman, Terra Firma Capital Partners.
00:10:00
Understanding Grand Strategy: A Historical Perspective
00:10:00
Scotiabank CEO Reflects on Strong Finish and Strategic Shifts for Future Growth | Brian Porter, CEO, Scotiabank.
00:10:00
Launching Beyond Borders: Canada's Future in Space Exploration Inspired by Apollo 11 | MARTIN BRASSARD - PRESIDENT AND CHIEF EXECUTIVE OFFICER of Héroux-Devtek
00:10:00
Pioneering Excellence: INV Metals' Path to Gold Production
00:10:00
Noront Resources Updates on Ring of Fire Nickel and Chromite Development Plans
00:10:00
Basel III: A Critical Look at Banking Reform and Risk | Insights from Wharton Experts